Knoll Capital Management, LLC

13F filer · CIK 0001325083

Reported Aug 14, 2026

Net buyer this quarter

13F portfolio value$179MU.S. long equity reported on 13F

Positions361 new · 1 closed

Net flow last quarter+$12.8MBuys minus sells

Top 10 positions weight58.8%Concentration

Holdings

13F · last 4 quarters free

Scroll for earlier quarters

Company	Value	% of portfolio	% of company	POSITION CHANGE qoq %	First reported
Q2 2026Reported Aug 14, 202636 positions
MGTXMeiraGTx Holdings plc	$16.9M	9.42%	1.33%	Not reported	Q3 2024
PHYSSprott Physical Gold Trust	$11.7M	6.51%	0.08%	Not reported	Q1 2026
ALDXAldeyra Therapeutics, Inc.	$11.7M	6.50%	9.08%	Not reported	Q1 2015
OCULOcular Therapeutix, Inc	$11.3M	6.30%	0.52%	+91.6%	Q1 2023
RGLDRoyal Gold Inc	$10.5M	5.87%	0.06%	Not reported	Q3 2023
ENTXEntera Bio Ltd.	$10.4M	5.81%	11.93%	Not reported	Q2 2018
NUVBNuvation Bio Inc.	$9.08M	5.06%	0.46%	+6.7%	Q1 2025
AEMAgnico Eagle Mines Ltd	$8.18M	4.56%	0.01%	Not reported	Q3 2020
SASeabridge Gold Inc	$8.16M	4.55%	0.34%	Not reported	Q3 2020
KGCKinross Gold Corp	$7.56M	4.22%	0.03%	Not reported	Q3 2023
OROR Royalties Inc.	$7.12M	3.97%	0.12%	Not reported	Q1 2026
SSRMSSR Mining Inc.	$6.93M	3.86%	0.12%	Not reported	Q4 2025
FNVFRANCO NEVADA Corp	$6.67M	3.72%	0.02%	Not reported	Q3 2020
BAHBooz Allen Hamilton Holding Corp	$5.69M	3.18%	0.01%	Not reported	Q1 2021
CGAUCenterra Gold Inc.	$5.69M	3.18%	0.18%	Not reported	Q2 2025
ELTXElicio Therapeutics, Inc.	$4.74M	2.64%	5.53%	+92.1%	Q1 2025
ABVXAbivax S.A.	$4.66M	2.60%	0.04%	New	Q2 2026
PAASPan American Silver Corp	$4.48M	2.50%	0.02%	Not reported	Q3 2020
PSLVSprott Physical Silver Trust	$4.19M	2.34%	0.04%	Not reported	Q1 2026
TFPMTriple Flag Precious Metals Corp.	$3.45M	1.92%	0.06%	Not reported	Q3 2025
ABEOAbeona Therapeutics Inc.	$3M	1.67%	0.85%	Not reported	Q2 2015
GROYGold Royalty Corp.	$2.76M	1.54%	0.45%	Not reported	Q1 2026
NEWPNew Pacific Metals Corp	$1.95M	1.09%	0.26%	Not reported	Q3 2023
PMPhilip Morris International Inc.	$1.81M	1.01%	0.00%	Not reported	Q4 2023
CDECoeur Mining, Inc.	$1.57M	0.87%	0.01%	Not reported	Q1 2025
AGIAlamos Gold Inc	$1.52M	0.85%	0.01%	Not reported	Q3 2023
WPMWheaton Precious Metals Corp.	$1.4M	0.78%	0.00%	Not reported	Q2 2022
NOCNorthrop Grumman Corp	$1.1M	0.61%	0.00%	Not reported	Q1 2023
ELEElemental Royalty Corp	$873K	0.49%	Not reported	Not reported	Q1 2026
VMETVersamet Royalties Corp	$821K	0.46%	0.07%	Not reported	Q1 2026
DCDakota Gold Corp.	$524K	0.29%	0.09%	Not reported	Q3 2025
AMRZAmrize Ltd	$489K	0.27%	0.00%	Not reported	Q1 2026
ALTAltimmune, Inc.	$486K	0.27%	0.08%	Not reported	Q4 2020
PHARPharming Group N.V.	$56.8K	0.03%	0.00%	+0.8%	Q1 2026
ORGSOrgenesis Inc.	$20.8K	0.01%	Not reported	Not reported	Q2 2020
BHVNBiohaven Ltd.	$15	0.00%	1.54%	Not reported	Q2 2017
Q1 2026Reported May 15, 202636 positions
BHVNBiohaven Ltd.	$19.7M	10.93%	1.55%	Not reported	Q2 2017
PHYSSprott Physical Gold Trust	$13.7M	7.61%	0.08%	New	Q1 2026
RGLDRoyal Gold Inc	$13.4M	7.45%	0.06%	Not reported	Q3 2023
MGTXMeiraGTx Holdings plc	$10.8M	6.01%	1.53%	Not reported	Q3 2024
AEMAgnico Eagle Mines Ltd	$10.7M	5.94%	0.01%	Not reported	Q3 2020
KGCKinross Gold Corp	$9.77M	5.42%	0.03%	-22.0%	Q3 2023
ALDXAldeyra Therapeutics, Inc.	$9.25M	5.14%	9.08%	Not reported	Q1 2015
SASeabridge Gold Inc	$8.98M	4.99%	0.34%	Not reported	Q3 2020
FNVFRANCO NEVADA Corp	$7.91M	4.39%	0.02%	+28.0%	Q3 2020
SSRMSSR Mining Inc.	$7.2M	4.00%	0.11%	Not reported	Q4 2025
ELTXElicio Therapeutics, Inc.	$6.74M	3.74%	3.38%	Not reported	Q1 2025
ENTXEntera Bio Ltd.	$6.47M	3.59%	12.62%	Not reported	Q2 2018
NUVBNuvation Bio Inc.	$6.43M	3.57%	0.43%	Not reported	Q1 2025
CGAUCenterra Gold Inc.	$6.39M	3.54%	0.18%	-27.8%	Q2 2025
PAASPan American Silver Corp	$5.46M	3.03%	0.02%	Not reported	Q3 2020
PSLVSprott Physical Silver Trust	$5.42M	3.01%	0.04%	New	Q1 2026
OCULOcular Therapeutix, Inc	$5.09M	2.82%	0.27%	Not reported	Q1 2023
TFPMTriple Flag Precious Metals Corp.	$3.99M	2.22%	0.06%	+95.6%	Q3 2025
GROYGold Royalty Corp.	$3.58M	1.99%	0.45%	New	Q1 2026
AGIAlamos Gold Inc	$2.22M	1.23%	0.01%	Not reported	Q3 2023
ABEOAbeona Therapeutics Inc.	$2.18M	1.21%	0.85%	+105.8%	Q2 2015
NEWPNew Pacific Metals Corp	$2.01M	1.11%	0.28%	Not reported	Q3 2023
CDECoeur Mining, Inc.	$1.8M	1.00%	0.01%	Not reported	Q1 2025
PMPhilip Morris International Inc.	$1.65M	0.92%	0.00%	Not reported	Q4 2023
WPMWheaton Precious Metals Corp.	$1.64M	0.91%	0.00%	Not reported	Q2 2022
NOCNorthrop Grumman Corp	$1.48M	0.82%	0.00%	Not reported	Q1 2023
BAHBooz Allen Hamilton Holding Corp	$1.01M	0.56%	0.01%	Not reported	Q1 2021
ELEElemental Royalty Corp	$943K	0.52%	Not reported	New	Q1 2026
VMETVersamet Royalties Corp	$634K	0.35%	0.07%	New	Q1 2026
DCDakota Gold Corp.	$621K	0.34%	0.09%	Not reported	Q3 2025
AMRZAmrize Ltd	$514K	0.29%	0.00%	New	Q1 2026
ALTAltimmune, Inc.	$493K	0.27%	0.12%	-85.7%	Q4 2020
CRDLCardiol Therapeutics Inc.	$135K	0.07%	0.10%	Not reported	Q2 2024
PHARPharming Group N.V.	$67.5K	0.04%	0.00%	New	Q1 2026
ORGSOrgenesis Inc.	$30.4K	0.02%	Not reported	Not reported	Q2 2020
OROR Royalties Inc.	$8.56K	0.00%	0.12%	New	Q1 2026
Q4 2025Reported Feb 17, 202632 positions
ALDXAldeyra Therapeutics, Inc.	$28.4M	13.01%	9.10%	Not reported	Q1 2015
BHVNBiohaven Ltd.	$26.3M	12.06%	1.75%	+160.1%	Q2 2017
NUVBNuvation Bio Inc.	$13.4M	6.16%	0.43%	+46.2%	Q1 2025
AVDLAvadel Pharmaceuticals PLC	$12.9M	5.93%	0.61%	Not reported	Q4 2022
GLDSPDR Gold Trust	$12.7M	5.82%	0.01%	Not reported	Q1 2024
RGLDRoyal Gold Inc	$11.7M	5.38%	0.06%	+486.1%	Q3 2023
KGCKinross Gold Corp	$11.5M	5.30%	0.03%	Not reported	Q3 2023
ENTXEntera Bio Ltd.	$11.4M	5.23%	12.74%	Not reported	Q2 2018
MGTXMeiraGTx Holdings plc	$9.94M	4.56%	1.54%	Not reported	Q3 2024
SASeabridge Gold Inc	$9.38M	4.30%	0.34%	Not reported	Q3 2020
AEMAgnico Eagle Mines Ltd	$8.94M	4.10%	0.01%	Not reported	Q3 2020
OCULOcular Therapeutix, Inc	$7.28M	3.34%	0.28%	Not reported	Q1 2023
CGAUCenterra Gold Inc.	$7.15M	3.28%	0.25%	Not reported	Q2 2025
SSRMSSR Mining Inc.	$5.37M	2.46%	0.12%	New	Q4 2025
PAASPan American Silver Corp	$5.18M	2.38%	0.02%	Not reported	Q3 2020
FNVFRANCO NEVADA Corp	$5.18M	2.38%	0.01%	Not reported	Q3 2020
SLViShares Silver Trust	$5.15M	2.36%	0.01%	Not reported	Q1 2024
ELTXElicio Therapeutics, Inc.	$5.02M	2.30%	3.54%	Not reported	Q1 2025
ALTAltimmune, Inc.	$4.05M	1.86%	1.01%	Not reported	Q4 2020
TFPMTriple Flag Precious Metals Corp.	$1.95M	0.90%	0.03%	Not reported	Q3 2025
AGIAlamos Gold Inc	$1.93M	0.88%	0.01%	Not reported	Q3 2023
CDECoeur Mining, Inc.	$1.71M	0.79%	0.02%	Not reported	Q1 2025
NEWPNew Pacific Metals Corp	$1.7M	0.78%	0.28%	Not reported	Q3 2023
PMPhilip Morris International Inc.	$1.6M	0.74%	0.00%	Not reported	Q4 2023
WPMWheaton Precious Metals Corp.	$1.47M	0.67%	0.00%	Not reported	Q2 2022
ABEOAbeona Therapeutics Inc.	$1.24M	0.57%	0.43%	+276.4%	Q2 2015
NOCNorthrop Grumman Corp	$1.23M	0.57%	0.00%	Not reported	Q1 2023
BAHBooz Allen Hamilton Holding Corp	$1.1M	0.50%	0.01%	Not reported	Q1 2021
DCDakota Gold Corp.	$698K	0.32%	0.11%	Not reported	Q3 2025
APLTApplied Therapeutics, Inc.	$605K	0.28%	4.19%	-22.4%	Q2 2019
CRDLCardiol Therapeutics Inc.	$95.3K	0.04%	0.10%	Not reported	Q2 2024
ORGSOrgenesis Inc.	$7.59K	0.00%	Not reported	Not reported	Q2 2020
Q3 2025Reported Nov 14, 202537 positions
ALDXAldeyra Therapeutics, Inc.	$28.6M	15.32%	9.10%	Not reported	Q1 2015
BHVNBiohaven Ltd.	$13.4M	7.20%	0.85%	Not reported	Q2 2017
GLDSPDR Gold Trust	$11.4M	6.10%	0.01%	Not reported	Q1 2024
ENTXEntera Bio Ltd.	$11.3M	6.05%	12.88%	Not reported	Q2 2018
MGTXMeiraGTx Holdings plc	$10.3M	5.51%	1.55%	Not reported	Q3 2024
KGCKinross Gold Corp	$10.2M	5.46%	0.03%	-6.8%	Q3 2023
AVDLAvadel Pharmaceuticals PLC	$9.16M	4.91%	0.62%	Not reported	Q4 2022
AEMAgnico Eagle Mines Ltd	$8.89M	4.76%	0.01%	-5.0%	Q3 2020
SSLSasol Ltd	$8.76M	4.70%	Not reported	Not reported	Q1 2025
SASeabridge Gold Inc	$7.66M	4.10%	0.34%	Not reported	Q3 2020
OCULOcular Therapeutix, Inc	$7.02M	3.76%	0.34%	Not reported	Q1 2023
ELTXElicio Therapeutics, Inc.	$6.9M	3.70%	3.66%	Not reported	Q1 2025
FNVFRANCO NEVADA Corp	$5.57M	2.99%	0.01%	Not reported	Q3 2020
NUVBNuvation Bio Inc.	$5.54M	2.97%	0.30%	Not reported	Q1 2025
CGAUCenterra Gold Inc.	$5.34M	2.86%	0.24%	-59.5%	Q2 2025
APLTApplied Therapeutics, Inc.	$4.71M	2.52%	5.41%	Not reported	Q2 2019
ALTAltimmune, Inc.	$4.23M	2.27%	1.17%	Not reported	Q4 2020
PAASPan American Silver Corp	$3.87M	2.08%	0.03%	Not reported	Q3 2020
SLViShares Silver Trust	$3.39M	1.82%	0.02%	Not reported	Q1 2024
RGLDRoyal Gold Inc	$1.81M	0.97%	0.01%	Not reported	Q3 2023
CDECoeur Mining, Inc.	$1.8M	0.97%	0.02%	Not reported	Q1 2025
AGIAlamos Gold Inc	$1.74M	0.93%	0.01%	Not reported	Q3 2023
TFPMTriple Flag Precious Metals Corp.	$1.72M	0.92%	0.03%	New	Q3 2025
VVisa Inc.	$1.66M	0.89%	0.00%	Not reported	Q1 2021
PMPhilip Morris International Inc.	$1.62M	0.87%	0.00%	Not reported	Q4 2023
WPMWheaton Precious Metals Corp.	$1.4M	0.75%	0.00%	Not reported	Q2 2022
NOCNorthrop Grumman Corp	$1.32M	0.71%	0.00%	Not reported	Q1 2023
NEWPNew Pacific Metals Corp	$1.31M	0.70%	0.28%	Not reported	Q3 2023
BAHBooz Allen Hamilton Holding Corp	$1.3M	0.70%	0.01%	Not reported	Q1 2021
DEODiageo PLC	$644K	0.35%	0.00%	Not reported	Q1 2024
DCDakota Gold Corp.	$559K	0.30%	0.11%	New	Q3 2025
MREOMereo BioPharma Group plc	$537K	0.29%	0.03%	Not reported	Q4 2023
HOOKHookipa Pharma Inc.	$461K	0.25%	2.31%	Not reported	Q4 2022
OBIOOrchestra BioMed Holdings, Inc.	$421K	0.23%	0.81%	Not reported	Q2 2025
ABEOAbeona Therapeutics Inc.	$331K	0.18%	0.12%	Not reported	Q2 2015
CRDLCardiol Therapeutics Inc.	$107K	0.06%	0.12%	Not reported	Q2 2024
ORGSOrgenesis Inc.	$50.6K	0.03%	Not reported	Not reported	Q2 2020

Premium opens every quarter this fund has filed